Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCarroll, D. R.
Right arrow Articles by Montgomery, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCarroll, D. R.
Right arrow Articles by Montgomery, R. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease

DR McCarroll, ZM Ruggeri and RR Montgomery

The infusion of 1-deamino-(8-D-arginine)-vasopressin (DDAVP) causes not only an elevation in factor VIII-related antigen (FVIIIR:Ag), but also a marked elevation of plasma von Willebrand antigen II (vWAgII). vWAgII reaches a peak concentration at 60 min and is elevated 3-8-fold over basal levels in normal individuals and individuals with type I, IIA, and IIB von Willebrand's disease. As the mechanism of hemostatic alteration brought about by DDAVP might be due to release of endothelial cell proteins, endothelial cell cultures were performed. The cultures demonstrated synthesis and secretion of vWAgII, as evidenced by the incorporation of 35S-methionine into the vWAgII molecule. Thus, vWAgII, like FVIIIR:Ag, is an endothelial cell protein.

Volume 63, Issue 3, pp. 532-535, 03/01/1984
Copyright © 1984 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
P.L. Turecek, L. Pichler, W. Auer, G. Eder, K. Varadi, A. Mitterer, W. Mundt, U. Schlokat, F. Dorner, L.O. Drouet, et al.
Evidence for Extracellular Processing of Pro-von Willebrand Factor After Infusion in Animals With and Without Severe von Willebrand Disease
Blood, September 1, 1999; 94(5): 1637 - 1647.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
M. Quitt, P. Froom, A. Veisler, V. Falber, J. Sova, and E. Aghai
The Effect of Desmopressin on Massive Gastrointestinal Bleeding in Hereditary Telangiectasia Unresponsive to Treatment With Cryoprecipitate
Arch Intern Med, August 1, 1990; 150(8): 1744 - 1746.
[Abstract] [PDF]

Home page
 ScienceHome page
P. Fay, Y Kawai, D. Wagner, D Ginsburg, D Bonthron, B. Ohlsson-Wilhelm, S. Chavin, G. Abraham, R. Handin, S. Orkin, et al.
Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II
Science, May 23, 1986; 232(4753): 995 - 998.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
D. W. RICHARDSON and A. G. ROBINSON
Drugs Five Years Later: Desmopressin
Ann Intern Med, August 1, 1985; 103(2): 228 - 239.
[Abstract] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1984 by American Society of Hematology         Online ISSN: 1528-0020